| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
4,018 |
2,987 |
$281K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
346 |
294 |
$29K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,911 |
2,350 |
$15K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
78 |
74 |
$3K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,116 |
803 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
401 |
154 |
$2K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
61 |
58 |
$972.24 |
| 99215 |
Prolong outpt/office vis |
79 |
72 |
$907.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
58 |
42 |
$291.72 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
126 |
94 |
$138.65 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
149 |
99 |
$85.44 |
| 99000 |
|
26 |
14 |
$24.50 |
| 3074F |
|
546 |
458 |
$0.00 |
| 3079F |
|
77 |
69 |
$0.00 |
| 3008F |
|
12 |
12 |
$0.00 |
| 3075F |
|
17 |
12 |
$0.00 |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
24 |
14 |
$0.00 |
| 3078F |
|
584 |
481 |
$0.00 |
| 3077F |
|
22 |
13 |
$0.00 |